Xylem (XYL) Tops Q1 EPS by 6c

Xylem (NYSE: XYL) reported Q1 EPS of $0.47, $0.06 better than the analyst estimate of $0.41. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.23 billion.

GUIDANCE:

Xylem sees FY2022 EPS of $2.40-$2.70, versus the consensus of $2.54.

For earnings history and earnings-related data on Xylem (XYL) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c